TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 18234433

Group type: EXPERIMENTAL
Intervention: Involved field radiotherapy (IF-RT) at 30 Gy
Number of subjects: 1779

Group type: EXPERIMENTAL
Intervention: Involved field radiotherapy (IF-RT) at 20 Gy
Number of subjects: 1779

Group type: COMPARATOR
Intervention: Involved field radiotherapy (IF-RT)
Number of subjects: 1779
Study: 16685221

Group type: EXPERIMENTAL
Intervention: Combination therapy for blood pressure lowering
Number of subjects: 6105

Group type: EXPERIMENTAL
Intervention: Single-drug therapy
Number of subjects: 6105

Group type: EXPERIMENTAL
Intervention: Achieved follow-up BP levels
Number of subjects: 6105

Group type: EXPERIMENTAL
Intervention: Lower BP levels
Number of subjects: 6105
Study: 15735329

Group type: EXPERIMENTAL
Intervention: Tai Chi (TC)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Vestibular rehabilitation (VR)
Number of subjects: 26
Study: 11341669

Group type: EXPERIMENTAL
Intervention: Famotidine
Number of subjects: 25
Study: 9236441

Group type: EXPERIMENTAL
Intervention: Spontaneous awake breathing
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Normal breathing
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Periodic breathing
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Cheyne‐Stokes respiration (CSR)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Controlled breathing
Number of subjects: 80

Group type: COMPARATOR
Intervention: Controlled ventilation
Number of subjects: 80
Study: 8237398

Group type: EXPERIMENTAL
Intervention: Metoprolol sustained-release tablets (Sino-Swed Pharmaceutical Co Ltd)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Metoprolol tablets from Sweden Astra International Pharmaceutical Co Ltd
Number of subjects: 12
Study: 2960719

Group type: EXPERIMENTAL
Intervention: T3 25 micrograms
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 30475647

Group type: EXPERIMENTAL
Intervention: En masse retraction (ER)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Two-step retraction (TSR)
Number of subjects: 48
Study: 29216331

Group type: EXPERIMENTAL
Intervention: Combined short- and long-axis (SLA) approach
Number of subjects: 20

Group type: COMPARATOR
Intervention: Short-axis (SA) approach
Number of subjects: 20

Group type: COMPARATOR
Intervention: Combined short- and long-axis (SLA) approach vs Short-axis (SA) approach
Number of subjects: 20
Study: 26054533

Group type: EXPERIMENTAL
Intervention: Single-fraction intensity-modulated RT (1 × 24 Gy)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Fractionated RT (10 × 3 Gy)
Number of subjects: 60
Study: 24127170

Group type: EXPERIMENTAL
Intervention: Bemiparin + matching placebo
Number of subjects: 206

Group type: COMPARATOR
Intervention: Unfractionated heparin (UFH)
Number of subjects: 206
Study: 22295543

Group type: COMPARATOR
Intervention: Ringer solution and 10% glucose solution in 1:1 ratio
Number of subjects: 139

Group type: EXPERIMENTAL
Intervention: Sterofundin-G-5 solution
Number of subjects: 139

Group type: EXPERIMENTAL
Intervention: Remaxol (800 ml/day)
Number of subjects: 139
Study: 19339148

Group type: EXPERIMENTAL
Intervention: MAAEZ intervention (Making Alcoholics Anonymous Easier)
Number of subjects: 508
Study: 16799281

Group type: EXPERIMENTAL
Intervention: Preventive Health Achievable Benchmarks Curriculum (multifaceted improvement intervention including individualized performance feedback, academic detailing by faculty, and collective didactic sessions)
Number of subjects: 208

Group type: COMPARATOR
Intervention: Control group residents (no specific intervention mentioned)
Number of subjects: 208
Study: 12922105

Group type: EXPERIMENTAL
Intervention: Engerix B
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Hepavax Gene
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Gen Hevac B
Number of subjects: 44
Study: 10869286

Group type: EXPERIMENTAL
Intervention: Steroids (40 mg/d prednisolone)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Enteral nutrition (2,000 kcal/d for 28 days)
Number of subjects: 71
Study: 9375539

Group type: EXPERIMENTAL
Intervention: 125 mg methylprednisolone (MP)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 45
Study: 8473585

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Psychodynamic therapy
Number of subjects: 62
Study: 3517407

Group type: EXPERIMENTAL
Intervention: Aztreonam (AZT) 1 g, twice a day by intravenous drip infusion for 5 days
Number of subjects: 394

Group type: COMPARATOR
Intervention: Cefoperazone (CPZ) 1 g, twice a day by intravenous drip infusion for 5 days
Number of subjects: 394

Group type: EXPERIMENTAL
Intervention: Aztreonam (AZT)
Number of subjects: 394

Group type: COMPARATOR
Intervention: Cefoperazone (CPZ)
Number of subjects: 394

Group type: EXPERIMENTAL
Intervention: Aztreonam (AZT) for Gram-negative bacteria
Number of subjects: 394

Group type: COMPARATOR
Intervention: Cefoperazone (CPZ) for Gram-negative bacteria
Number of subjects: 394
Study: 29898619

Group type: EXPERIMENTAL
Intervention: Obinutuzumab plus bendamustine (G + B) for up to 2 years
Number of subjects: 0

Group type: COMPARATOR
Intervention: Bendamustine monotherapy (B-monotherapy)
Number of subjects: 0
Study: 27898982

Group type: EXPERIMENTAL
Intervention: Cross-linked (PACK-CXL)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Infected and then cross-linked (PACK-CXL)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Infected
Number of subjects: 16

Group type: COMPARATOR
Intervention: Untreated control
Number of subjects: 16
Study: 24816395

Group type: EXPERIMENTAL
Intervention: Ara h 2
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Pru p 3
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Ara h 1
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Ara h 9
Number of subjects: 4
Study: 22688600

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy for pain
Number of subjects: 132
Study: 20714711

Group type: EXPERIMENTAL
Intervention: Dual-task condition where observers signalled the direction of the luminance change.
Number of subjects: 4

Group type: COMPARATOR
Intervention: Single-task condition where the discrimination stimulus was presented but could be ignored.
Number of subjects: 4
Study: 18929283

Group type: EXPERIMENTAL
Intervention: 0.5 microg kg(‐1) dexmedetomidine (group D, n = 20)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Saline solution (group C, n = 20)
Number of subjects: 40
Study: 15879168

Group type: EXPERIMENTAL
Intervention: High carbohydrate diet (HCHO)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Low carbohydrate diet (LCHO)
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Both diets (HCHO and LCHO)
Number of subjects: 2
Study: 12410458

Group type: EXPERIMENTAL
Intervention: Highly cross‐linked hyaluronic acid (HA)
Number of subjects: 111

Group type: COMPARATOR
Intervention: Gaseous oxygen (O2)
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 111
Study: 12063216

Group type: EXPERIMENTAL
Intervention: 0.2-T T1-weighted SE imaging
Number of subjects: 287

Group type: COMPARATOR
Intervention: 1.5-T MR imaging
Number of subjects: 287
Study: 9874906

Group type: EXPERIMENTAL
Intervention: Nortriptyline hydrochloride (NT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Interpersonal psychotherapy (IPT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 7735371

Group type: EXPERIMENTAL
Intervention: Octreotide (somatostatin analog) for 21 days after diagnosis
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (age-matched diabetic children)
Number of subjects: 20
Study: 2646895

Group type: EXPERIMENTAL
Intervention: Simvastatin 20 mg once daily
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Simvastatin 40 mg once daily
Number of subjects: 0

Group type: COMPARATOR
Intervention: Probucol 500 mg twice daily
Number of subjects: 0
Study: 31300025

Group type: EXPERIMENTAL
Intervention: Stemless total shoulder arthroplasty
Number of subjects: 80

Group type: COMPARATOR
Intervention: Stemmed total shoulder arthroplasty
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 80
Study: 29072162

Group type: EXPERIMENTAL
Intervention: Homogenized Holder-pasteurized human milk (PHHM)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Holder-pasteurized human milk (PHM)
Number of subjects: 8
Study: 25307416

Group type: EXPERIMENTAL
Intervention: Coping Power program
Number of subjects: 0
Study: 23462537

Group type: EXPERIMENTAL
Intervention: Wholegrain diet for 12 weeks
Number of subjects: 146

Group type: COMPARATOR
Intervention: Refined cereal diet for 12 weeks
Number of subjects: 146
Study: 21480105

Group type: EXPERIMENTAL
Intervention: Verbal information
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Written information
Number of subjects: 300

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 300
Study: 17473836

Group type: EXPERIMENTAL
Intervention: Erythropoietin (Epo) 40,000 IU
Number of subjects: 0

Group type: COMPARATOR
Intervention: Saline (Control)
Number of subjects: 0
Study: 17262143

Group type: EXPERIMENTAL
Intervention: OxaGel
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: experimental agent DD‐1
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: experimental agent DD‐2
Number of subjects: 50

Group type: COMPARATOR
Intervention: placebo gel
Number of subjects: 50

Group type: COMPARATOR
Intervention: deionized water
Number of subjects: 50
Study: 12943433

Group type: EXPERIMENTAL
Intervention: Clinical assessment
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Two-dimensional color transparencies
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Three-dimensional imaging
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Lay assessors' clinical assessment
Number of subjects: 31

Group type: COMPARATOR
Intervention: Standard clinical assessment
Number of subjects: 31
Study: 10636972

Group type: EXPERIMENTAL
Intervention: Glucomannan
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 9371897

Group type: EXPERIMENTAL
Intervention: Zolmitriptan 2.5 mg
Number of subjects: 327

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 327
Study: 1541105

Group type: EXPERIMENTAL
Intervention: Ultrasound-aided technique
Number of subjects: 56

Group type: COMPARATOR
Intervention: Conventional technique
Number of subjects: 56
Study: 31309348

Group type: EXPERIMENTAL
Intervention: APP+ mobile app intervention
Number of subjects: 90

Group type: COMPARATOR
Intervention: No-treatment control group
Number of subjects: 90
Study: 30221194

Group type: EXPERIMENTAL
Intervention: GLA-AF (aqueous formulation of glucopyranosyl lipid adjuvant)
Number of subjects: 0
Study: 26462806

Group type: EXPERIMENTAL
Intervention: Acute tryptophan depletion (ATD)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nutritionally balanced amino acid mixtures
Number of subjects: 0
Study: 24634299

Group type: EXPERIMENTAL
Intervention: Lamivudine and adefovir dipivoxil
Number of subjects: 77

Group type: COMPARATOR
Intervention: Autologous bone marrow stem cell transplantation combined with lamivudine and adefovir dipivoxil
Number of subjects: 77
Study: 22472173

Group type: EXPERIMENTAL
Intervention: Intramuscular delivery of 40 ml bone marrow cells (n = 21)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Intra-arterial delivery of 40 ml bone marrow cells (n = 20)
Number of subjects: 41
Study: 19919585

Group type: EXPERIMENTAL
Intervention: MgSO(4) 60 mg/kg
Number of subjects: 80

Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 80
Study: 18625536

Group type: EXPERIMENTAL
Intervention: 1 mg NA/5 microg EE
Number of subjects: 485

Group type: EXPERIMENTAL
Intervention: 1 mg NA/10 microg EE
Number of subjects: 485

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 485
Study: 16003271

Group type: EXPERIMENTAL
Intervention: Linear mapping of regional myocardial strain
Number of subjects: 20

Group type: COMPARATOR
Intervention: Arbitrary measurements
Number of subjects: 20
Study: 11809593

Group type: EXPERIMENTAL
Intervention: Finasteride 1 mg/day for one year
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 10518297

Group type: EXPERIMENTAL
Intervention: 4-week lumbar stabilization exercise program with weekly reinstruction
Number of subjects: 44

Group type: COMPARATOR
Intervention: Nonexercise group (control)
Number of subjects: 44
Study: 7552929

Group type: EXPERIMENTAL
Intervention: Topical levocabastine
Number of subjects: 21
Study: 1708719

Group type: EXPERIMENTAL
Intervention: Conditioned MEPs with nerve-TCS intervals between 16 and 20 msec for elbow stimulation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Conditioned MEPs with nerve-TCS intervals between 20 and 22 msec for wrist stimulation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Conditioned MEPs with nerve-TCS intervals corresponding to the sum of AT + CI (mean 23.2 msec, range 21.7-24.8)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Facilitated conditioned MEPs
Number of subjects: 0

Group type: COMPARATOR
Intervention: Segmental H reflex
Number of subjects: 0
Study: 6114279

Group type: EXPERIMENTAL
Intervention: Phenobarbitone
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study: 30969147

Group type: EXPERIMENTAL
Intervention: TIPS-Plus
Number of subjects: 240

Group type: COMPARATOR
Intervention: TIPS-Basic
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: TIPS-Plus and TIPS-Basic
Number of subjects: 240
Study: 28375035

Group type: EXPERIMENTAL
Intervention: Esmolol (5-10 µg/kg/min) in combination with propofol and remifentanil
Number of subjects: 56

Group type: COMPARATOR
Intervention: Normal saline (same volume as esmolol) in addition to propofol and remifentanil
Number of subjects: 56
Study: 26375604

Group type: EXPERIMENTAL
Intervention: Capsule formulations with hydroxypropyl methylcellulose (HPMC)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Capsule formulations with magnesium stearate
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Cimetidine commercial solution containing sorbitol
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Capsule formulations with lower amounts of HPMC and magnesium stearate
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Sorbitol-containing commercial solution
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Sorbitol-free solution
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: 12 common excipients in large amounts
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: HPMC and microcrystalline cellulose
Number of subjects: 72
Study: 24879885

Group type: EXPERIMENTAL
Intervention: Green low-fat label
Number of subjects: 287

Group type: EXPERIMENTAL
Intervention: Red high-fat label
Number of subjects: 287

Group type: COMPARATOR
Intervention: No label
Number of subjects: 287
Study: 22084448

Group type: EXPERIMENTAL
Intervention: OROS® methylphenidate (Concerta®)
Number of subjects: 139

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 139
Study: 19717185

Group type: EXPERIMENTAL
Intervention: Bivalirudin (0.75 mg/kg intravenous bolus followed by 1.75 mg/kg per h infusion)
Number of subjects: 3602

Group type: EXPERIMENTAL
Intervention: Bivalirudin
Number of subjects: 3602

Group type: COMPARATOR
Intervention: Heparin plus GPI (control)
Number of subjects: 3602
Study: 18003960

Group type: EXPERIMENTAL
Intervention: Cetuximab (400 mg/m² initial dose followed by 250 mg/m² weekly) plus best supportive care
Number of subjects: 572

Group type: COMPARATOR
Intervention: Best supportive care alone
Number of subjects: 572
Study: 14974945

Group type: EXPERIMENTAL
Intervention: EC‐MPS (720 mg b.i.d.)
Number of subjects: 322

Group type: COMPARATOR
Intervention: MMF (1000 mg b.i.d.)
Number of subjects: 322
Study: 11261909

Group type: EXPERIMENTAL
Intervention: Admixture of thiopentone and propofol (1.25% and 0.5% respectively)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Propofol 1%
Number of subjects: 81
Study: 9557929

Group type: EXPERIMENTAL
Intervention: Oral contraceptive pills (ethinyl-oestradiol plus levonorgestrel)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Low-fat diet
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Oral contraceptive pills
Number of subjects: 32
Study: 8300688

Group type: EXPERIMENTAL
Intervention: Modified over-the-top (OTT) procedure
Number of subjects: 54

Group type: COMPARATOR
Intervention: Tunnel position obtained by an isometric drill guide (ISO)
Number of subjects: 54
Study: 2656775

Group type: EXPERIMENTAL
Intervention: Captopril (50 mg twice daily)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Atenolol (50 mg twice daily)
Number of subjects: 23
Study: 31552577

Group type: COMPARATOR
Intervention: Carfilzomib-based therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Daratumumab-based therapy
Number of subjects: 0
Study: 31453723

Group type: EXPERIMENTAL
Intervention: Moderate-intensity exercise (MOD; 55% peak oxygen uptake)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: High-intensity exercise (HIGH; 75% peak oxygen uptake)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control (CON; rest)
Number of subjects: 10
Study: 28688245

Group type: EXPERIMENTAL
Intervention: 5mg prednisolone in the evening
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 5mg prednisolone (morning or evening)
Number of subjects: 8

Group type: COMPARATOR
Intervention: 5mg prednisolone in the morning
Number of subjects: 8
Study: 26604737

Group type: EXPERIMENTAL
Intervention: SFC250 + TIO
Number of subjects: 53

Group type: COMPARATOR
Intervention: TIO
Number of subjects: 53

Group type: COMPARATOR
Intervention: SFC250
Number of subjects: 53
Study: 23815878

Group type: EXPERIMENTAL
Intervention: Home-based exercise supported by Peer Mentors
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Class-based exercise
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study: 21088669

Group type: EXPERIMENTAL
Intervention: Sodium intake
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: DASH dietary pattern
Number of subjects: 0
Study: 19204207

Group type: EXPERIMENTAL
Intervention: Erlotinib
Number of subjects: 110

Group type: COMPARATOR
Intervention: Temozolomide or Carmustine (BCNU)
Number of subjects: 110
Study: 17539852

Group type: EXPERIMENTAL
Intervention: Inhaled corticosteroids and long-acting beta(2)-agonists
Number of subjects: 20

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 20
Study: 16252738

Group type: EXPERIMENTAL
Intervention: Fresh needle penetration in anterior hard palate
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Used needle penetration in buccal mucosa (women)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Used needle penetration in buccal mucosa (men)
Number of subjects: 24
Study: 12030995

Group type: EXPERIMENTAL
Intervention: Premedication with morphine, atropine and suxamethonium
Number of subjects: 20

Group type: COMPARATOR
Intervention: Awake intubation
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Premedicated group
Number of subjects: 20

Group type: COMPARATOR
Intervention: Unpremedicated group
Number of subjects: 20
Study: 9593989

Group type: EXPERIMENTAL
Intervention: More frequent trials in one direction (2:1 ratio)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Less frequent trials in the opposite direction
Number of subjects: 0
Study: 7636452

Group type: EXPERIMENTAL
Intervention: Ranitidine 150 mg twice daily
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 2677375

Group type: EXPERIMENTAL
Intervention: Indomethacin
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Sulindac
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 100624

Group type: EXPERIMENTAL
Intervention: Trimethoprim-sulfamethoxazole (4 tablets: trimethoprim 320 mg, sulfamethoxazole 1,600 mg) twice daily for two days
Number of subjects: 89

Group type: COMPARATOR
Intervention: Ampicillin (3.5 g) plus probenecid (1 g) in a single dose
Number of subjects: 89
Study: 30869027

Group type: EXPERIMENTAL
Intervention: Dromedary camels
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Bedouins
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Non-Bedouin Arabs
Number of subjects: 86

Group type: COMPARATOR
Intervention: Jews
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Age group ⩾40 years old in Bedouins
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Age group ⩾40 years old in non-Bedouin Arabs
Number of subjects: 86
Study: 28183155

Group type: EXPERIMENTAL
Intervention: Interim analyses with early stopping for futility
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Completed studies without stopping for futility
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Single study with stopping rule
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Interim analysis
Number of subjects: 0
Study: 25937021

Group type: EXPERIMENTAL
Intervention: CPIHD with hypertonic saline (3% NaCl)
Number of subjects: 64

Group type: COMPARATOR
Intervention: CPIHD with normal saline (0.9% NaCl)
Number of subjects: 64
Study: 23676630

Group type: EXPERIMENTAL
Intervention: Model based on anthropometric measurements
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: ViScan abdominal bioelectrical impedance analyzer
Number of subjects: 91
Study: 21270788

Group type: EXPERIMENTAL
Intervention: NicVAX (3'AmNic‐rEPA) 400-µg dose, five injections
Number of subjects: 301

Group type: EXPERIMENTAL
Intervention: NicVAX (3'AmNic‐rEPA) 200-µg dose, four or five injections
Number of subjects: 301

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 301
Study: 20084933

Group type: EXPERIMENTAL
Intervention: Moxibustion treatment
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group (no moxibustion)
Number of subjects: 90
Study: 16485612

Group type: EXPERIMENTAL
Intervention: Yoga for children
Number of subjects: 19

Group type: COMPARATOR
Intervention: Conventional motor exercises
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Yoga for children (in children undergoing pharmacotherapy)
Number of subjects: 19
Study: 15336451

Group type: EXPERIMENTAL
Intervention: PEG‐IFN plus ribavirin
Number of subjects: 311

Group type: COMPARATOR
Intervention: Standard interferon alfa‐2b (IFN) plus ribavirin
Number of subjects: 311
Study: 10847665

Group type: EXPERIMENTAL
Intervention: Increased physical exercise
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Smoking cessation
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Blood pressure and cholesterol change
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Total risk change
Number of subjects: 110
Study: 7475056

Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 28

Group type: COMPARATOR
Intervention: Atenolol
Number of subjects: 28